Références
GRACE N.D., GROSZMANN R.J., GARCIA-TSAO G., BURROUGHS A.K., PAGLIARO L., MAKUCH R.W.,et al. — Portal hypertension and variceal bleeding: an AASLD single topic symposium.Hepatology, 1998,28 (3), 868–880.
D’AMICO G., PAGLIARO L., BOSCH J. — The treatment of portal hypertension: a meta-analytic review.Hepatology, 1995,22 (1), 332–354.
GARCÍA-PAGÁN J.C., ESCORSELL A., MOITINHO E., BOSCH J. — Influence of pharmacological agents on portal hemodynamics: Basic for its use in the treatment of portal hypertension.Semin. Liver. Dis., 1999,19, 427–438.
PUGH R.N.H., MURRAY-LYON I.M., DAWSON J.L., PIETRONI M.C., WILLIAMS R. — Transection of the oesophagus for bleeding oesophageal varices.Brit. J. Surg., 1973,60, 646–664.
DE FRANCHIS R., PASCAL J.P., ANCONA E., BURROUGHS A.K., HENDERSON M., FLEIG W.et al. — Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.J. Hepatol., 1992,15, (1–2), 256–261.
SALERNO F., BORRONI G., LORENZANO E., SOLENGHI D., CAZZANIGA M., BISSOLI F.et al. — Long-term administration of isosorbide-5-monomitrate does not impair renal function in cirrhotic patients.Hepatology, 1996,23 (5), 1135–1140.
ESCORSELL A., BORDAS J.M., DEL ARBOL L.R., JARAMILLO J.L., PLANAS R., BANARES R.et al. — Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.J. Hepatol., 1998,29, (5), 779–788.
MOITINHO E., ESCORSELL A., BANDI J.C., SALMERON J.M., GARCIA-PAGAN J.C., RODES J.et al. — Prognostic value of early measurements of portal pressure in acute variceal bleeding.Gastroenterology, 1999,117(3), 626–631.
DUCOIN H., EL KHOURY J., ROUSSEAU H., BARANGE K., PERON J.M., PIERRAGI M.T.,et al. — Histopathologic analysis of transjugular intrahepatic protosystemic shunts.Hepatology, 1997,25 (5), 1064–1069.
READY J.B., ROBERTSON A.D., GOFF J.S., RECTOR W.G. Jr. —Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure.Gastroenterology, 1991,100 (5 Pt 1), 1403–1410.
CASTANEDA B., DEBERNARDI-VENON W., BANDI J.C., ANDREU V., PEREZ-DEL-PULGAR S., MOITINHO E.,et al. — The role of portal pressure in the severity of bleeding in portal hypertensive rats.Hepatology, 2000,31, (3), 581–586.
ESCORSELL A., BORDAS J.M., CASTANEDA B., LLACH J., GARCÍA-PAGÁN J.C., RODES J.et al. — Predictive value of the variceal pressure response to continuel pharmacological therapy in patients with cirrhosis and portal hypertension.Hepatology, 2000,31, (5), 1061–1067.
BOSCH J., GARCÍA-PAGÁN J.C. — Complications of cirrhosis. I. Portal hypertension.J. Hepatol., 2000,31, (1 Suppl), 141–156.
NIEC. — Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices [see comments].N. Engl. J. Med., 1988,319 (15), 983–989.
D’AMICO G., PAGLIARO L., BOSCH J. — Pharmacological treatment of portal hypertension: an evidence-based approach.Semin. Liver. Dis. 1999,19 (4), 475–505.
GOULIS J., PATCH D., BURROUGHS A.K. — Bacterial infection in the pathogenesis of variceal bleeding [see comments].Lancet, 1999,353 (9147), 139–142.
PISCAGLIA F., SIRINGO S., HERMIDA R.C., LEGNANI C., VALGIMIGLI M., DONATI G.et al. — Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.Hepatology, 2000,31 (2), 349–357.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bosch, J. Facteurs prédictifs de l’hémorragie par rupture de varices œsophagiennes. Acta Endosc 30, 531–535 (2000). https://doi.org/10.1007/BF03026170
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03026170